RPL30: A Key Protein Regulating Ribosome Function (G6156)

Target Name: RPL30

NCBI ID: G6156

RPL30

RPL30: A Key Protein Regulating Ribosome Function

Ribosomal protein L30 (RPL30) is a protein that is synthesized in the ribosome, which is a complex organelle that is responsible for the translation of DNA into proteins. RPL30 is a key protein that helps keep the ribosome functioning properly. It is made up of 21 kilodalton (kDa) and has a molecular weight of 30 kDa. RPL30 is found in all eukaryotic cells and is expressed in high levels in muscle, heart, and liver cells. It is also expressed in the brain, where it is a key protein in the development and maintenance of neural networks.

One of the functions of RPL30 is to help regulate the activity of the ribosome. The ribosome is responsible for synthesizing the proteins that are built on the ribosome during the translation of DNA. RPL30 helps to keep the ribosome in a state of activity, which is necessary for protein synthesis to occur.

Another function of RPL30 is to help keep the ribosome in a state of stability. The ribosome is constantly trying to fuse together with the mRNA in order to begin the process of protein synthesis. RPL30 helps to hold the ribosome together, which is necessary for the fusing process to occur properly.

In addition to its role in regulating the ribosome, RPL30 is also a potential drug target. Studies have shown that RPL30 can be targeted by small molecules, which could make it an attractive target for drug development. One of the small molecules that has been shown to interact with RPL30 is called TK-22, which is a compound that is currently being tested as a potential drug for the treatment of various diseases, including cancer.

Another potential drug that may target RPL30 is called VX-950, which is a compound that is being developed as a potential treatment for various diseases, including cancer. VX-950 is a small molecule that is similar to the natural compound TK-22, which has been shown to interact with RPL30.

In conclusion, RPL30 is a protein that plays a critical role in regulating the activity of the ribosome. It is also a potential drug target, and studies have shown that small molecules have the potential to interact with RPL30. Further research is needed to fully understand the role of RPL30 in protein synthesis and to identify potential drugs that can target it.

Protein Name: Ribosomal Protein L30

Functions: Component of the large ribosomal subunit (PubMed:23636399, PubMed:32669547). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399, PubMed:32669547)

The "RPL30 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL30 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets